Research Library | Reta Compare

20 research articles. Page 1 of 1.

Articles

• Retatrutide Mechanism of Action: How the GLP-1/GIP/Glucagon Triple Agonist Works
• The Role of Glucagon Receptor Agonism in Retatrutide's Metabolic Effects
• Retatrutide and Energy Expenditure: How the Glucagon Component Burns Calories
• How Does Glucagon Receptor Agonism Promote Weight Loss?
• What Are Glucagon-Like Peptide-2 Analogs?
• Retatrutide Mechanism: GLP-1 / GIP / Glucagon Receptor Activity
• Exploring Retatrutide: Insights from Glucagon Receptor Agonism in Obesity Treatment
• Exploring Retatrutide's Role in Glucagon Signaling for Metabolic Disorders
• Exploring the Quad-Agonist Combination of GLP-1, GIP, Glucagon, and Amylin
• GLP-1 + GIP + Glucagon + FGF21: Enhancing Fatty Liver Activity
• GLP-1 + GIP + Glucagon + PYY/Y2: Enhancing Satiety through Multi-Agonism
• Exploring the Potential of a Quad-Agonist Combination: GLP-1, GIP, Glucagon, and GDF15
• GLP-1 and Glucagon Dual Agonists: A Foundation for Future Triple and Quad Therapies
• GLP-1 + GIP + Glucagon Triple Agonists: Retatrutide as the Benchmark for Future Multi-Agonist Therapies
• Penta-Agonist Concept: Integrating GLP-1, GIP, Glucagon, Amylin, and FGF21 in a Single Molecule
• Exploring the Penta-Agonist Concept: GLP-1, GIP, Glucagon, Amylin, and Y2 Receptor Interplay
• Altimmune Pemvidutide: GLP-1/Glucagon Dual Focused on NASH
• Glucagon Receptor Mechanism: Enhancing Energy Expenditure and Reducing Hepatic Fat
• Amylin Receptor Mechanism: Understanding Satiety, Gastric Emptying, and Glucagon Suppression
• Safety Considerations for Glucagon Receptor Agonism in Quad Drugs